By Counterforce Health Team in Xospata (gilteritinib) —

Get Xospata (Gilteritinib) Covered by Cigna in Texas: Complete Guide to Prior Authorization and Appeals

Answer Box: Your Path to Xospata Coverage

Cigna requires prior authorization for Xospata (gilteritinib) in Texas. To get approved: (1) Ensure you have relapsed/refractory AML with documented FLT3 mutation via FDA-approved test, (2) Have your hematologist/oncologist submit prior authorization with complete treatment history, and (3) If denied, file internal appeal within 180 days, then external review through Texas Department of Insurance if needed. Start today: Contact your oncology team to confirm FLT3 testing and gather prior therapy records. Appeals succeed when clinical criteria are met—Texas law guarantees independent review if Cigna denies medically necessary treatment.

Table of Contents

  1. Coverage Basics
  2. Prior Authorization Process
  3. Timing and Deadlines
  4. Clinical Criteria Requirements
  5. Costs and Financial Assistance
  6. Denials and Appeals in Texas
  7. Renewal and Reauthorization
  8. Specialty Pharmacy Transfer
  9. Common Questions Answered
  10. When to Escalate

Coverage Basics

Is Xospata covered by Cigna? Yes, but with restrictions. Cigna covers Xospata (gilteritinib) for adults with relapsed or refractory acute myeloid leukemia (AML) that's FLT3 mutation-positive. Coverage requires prior authorization and is typically approved for one year when clinical criteria are met.

Which Cigna plans cover it? Both commercial plans and Medicare Advantage plans in Texas cover Xospata, though it's classified as a specialty drug requiring higher cost-sharing. The medication is managed through Express Scripts/Accredo specialty pharmacy network.

Note: Self-funded employer plans (ERISA) may have different requirements and aren't subject to Texas state appeal protections.

Coverage at a Glance

Requirement What It Means Where to Find It
Prior Authorization Required before coverage Cigna PA Policy
Formulary Tier Tier 4/5 (Specialty) Texas Drug List
Age Requirement 18+ years FDA labeling
Prescriber Hematologist/Oncologist Cigna PA requirements
FLT3 Testing FDA-approved test required Clinical documentation

Prior Authorization Process

Step-by-Step: Fastest Path to Approval

  1. Confirm FLT3 Mutation Status (Patient/Clinic)
    • Ensure you have FDA-approved FLT3 mutation test results
    • Timeline: If testing needed, allow 5-7 business days
    • Document: Lab report showing FLT3-ITD or FLT3-TKD mutation
  2. Gather Treatment History (Clinic)
    • Document all prior AML therapies, dates, and outcomes
    • Include reasons for treatment failures or intolerances
    • Timeline: 1-2 days to compile records
  3. Submit Prior Authorization (Hematologist/Oncologist)
    • Use Cigna provider portal or designated PA process
    • Include: PA form, FLT3 test results, treatment history, clinical notes
    • Timeline: Submit electronically for fastest processing
  4. Cigna Review Process
    • Standard review: 72 hours for routine requests
    • Expedited review: 24 hours for urgent cases
    • Decision communicated to prescriber and patient
  5. If Approved
    • Transfer prescription to Accredo Specialty Pharmacy
    • Coordinate delivery and patient education
    • Coverage approved for up to one year

Timing and Deadlines

How long does prior authorization take? Cigna must respond within 72 hours for standard requests and 24 hours for urgent requests. Incomplete submissions may cause delays.

Urgent/expedited requests are available when delay would seriously jeopardize your health. Your oncologist must document the medical urgency.

Texas Appeals Timeline

Step Deadline Timeline for Decision
Internal Appeal 180 days from denial 30 days (pre-service)
External Review (IRO) 4 months from final denial 3 days (urgent), 30 days (standard)

Clinical Criteria Requirements

Required Documentation for Approval

Diagnosis Requirements:

  • Adult patient (≥18 years) with relapsed or refractory AML
  • FLT3 mutation-positive disease confirmed by FDA-approved test
  • Documentation of prior therapy failures

Prescriber Requirements:

  • Must be submitted by or in consultation with hematologist/oncologist
  • Clinical notes supporting medical necessity
  • Monitoring plan for potential side effects

Exclusions:

  • Severe renal impairment (CrCl <30 ml/min)
  • Severe hepatic impairment (Child-Pugh C)
  • Use as first-line therapy (unless supported by compendia)
Clinician Corner: Your medical necessity letter should include: (1) specific AML subtype and FLT3 mutation details, (2) chronological list of prior therapies with dates and outcomes, (3) current disease status and treatment goals, (4) rationale for Xospata based on NCCN guidelines, and (5) monitoring plan for differentiation syndrome and QT prolongation.

Costs and Financial Assistance

What will I pay? Xospata is typically placed in Tier 4 or 5 (specialty tier) on Cigna formularies, with coinsurance rates of 30-50% or copays ranging from $250-$500+ per fill. Exact costs depend on your specific plan design.

Cost at wholesale: Approximately $28,979 for a 30-day supply (120 mg daily dosing).

Financial Assistance Options

  • Xospata Patient Savings Program: May reduce copays to $0 for eligible patients with commercial insurance
  • Medicare patients: Not eligible for manufacturer copay assistance but may qualify for foundation grants
  • Uninsured/underinsured: Patient assistance program available through Astellas

Denials and Appeals in Texas

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn
Missing FLT3 mutation report Submit FDA-approved test results with clear mutation type
Insufficient prior therapy documentation Provide detailed treatment history with dates and outcomes
Non-hematology prescriber Have hematologist/oncologist submit or co-sign request
"Not medically necessary" Include NCCN guideline citations and treatment rationale

Texas Appeals Process

Internal Appeals with Cigna:

  1. File within 180 days of denial
  2. Submit additional clinical documentation
  3. Request peer-to-peer review if available
  4. Cigna has 30 days to decide pre-service appeals

External Review (If Internal Appeal Denied):

  1. Request Independent Review Organization (IRO) through Texas Department of Insurance
  2. File within 4 months of final Cigna denial
  3. IRO decision is binding on Cigna
  4. Timeline: 3 business days for urgent cases, 30 days for standard
Important: These Texas protections apply only to state-regulated plans. ERISA self-funded employer plans follow federal appeal processes.

Renewal and Reauthorization

When do I need to renew? Cigna typically approves Xospata for one-year periods. Your oncologist should submit reauthorization 30-60 days before expiration.

What's needed for renewal?

  • Updated clinical notes showing continued medical necessity
  • Current labs and disease status
  • Documentation of treatment tolerance and response
  • Continued hematologist/oncologist supervision

Specialty Pharmacy Transfer

Why was my prescription transferred? Cigna requires specialty drugs like Xospata to be filled through their preferred network, typically Accredo Specialty Pharmacy.

Transfer Process

  1. Call Accredo: 877-826-7657 (M-F 7am-10pm CST, Sat 7am-4pm CST)
  2. Provide information: Cigna ID, prescriber details, current pharmacy
  3. Accredo handles transfer: They coordinate with your previous pharmacy and doctor
  4. Delivery setup: Usually 1-2 day shipping with temperature control

Benefits of specialty pharmacy:

  • Clinical support from oncology-trained pharmacists
  • Insurance benefits verification
  • Side effect monitoring and education
  • Coordination with your care team

Common Questions Answered

Q: How long does Cigna prior authorization take in Texas? A: Standard requests: 72 hours, urgent requests: 24 hours. Incomplete submissions may cause delays.

Q: What if Xospata is non-formulary on my plan? A: You can request a formulary exception through Cigna's pharmacy exception process with clinical justification from your oncologist.

Q: Can I request an expedited appeal in Texas? A: Yes, if delay would seriously jeopardize your health. Both Cigna internal appeals and Texas IRO external reviews offer expedited timelines for urgent cases.

Q: Does step therapy apply if I've already failed other treatments? A: Prior treatment failures should satisfy step therapy requirements. Document all previous therapies with dates and reasons for discontinuation.

Q: What counts as medical necessity for Xospata? A: Relapsed/refractory AML with FLT3 mutation confirmed by FDA-approved test, appropriate prior therapy trials, and ongoing hematologist/oncologist care per Cigna's clinical criteria.

When to Escalate

Contact these Texas resources if you need additional help:

  • Texas Department of Insurance: 1-800-252-3439 for coverage disputes and IRO requests
  • Office of Public Insurance Counsel: 1-877-611-6742 for consumer assistance
  • Disability Rights Texas: Legal advocacy for complex cases

For urgent situations where treatment delays could be life-threatening, don't hesitate to involve your oncologist in requesting expedited reviews at every level.

Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned with payer requirements, pulling the right clinical evidence and meeting procedural deadlines. We've seen that appeals often succeed when the right documentation meets specific payer criteria—especially for specialty oncology drugs where clinical guidelines strongly support treatment decisions.

Throughout this process, remember that Counterforce Health specializes in helping patients navigate complex prior authorization and appeal processes. If you're facing repeated denials or need help organizing clinical documentation for appeals, professional advocacy can make the difference between approval and ongoing treatment delays.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage varies by plan and individual circumstances. Always consult with your healthcare provider about treatment decisions and verify current coverage requirements with your insurer. Texas appeal rights may not apply to all plan types.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.